Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy

NCT06382103 · clinicaltrials.gov ↗

RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DIAGNOSTIC_TEST: ctDNA monitoring
DIAGNOSTIC_TEST: Plasma proteomic analysis

Sponsor

Shanghai Zhongshan Hospital